+

US20060079715A1 - Production of 2-amino-2-(4-alkylphenyl)ethyl]propane-1,3-diols - Google Patents

Production of 2-amino-2-(4-alkylphenyl)ethyl]propane-1,3-diols Download PDF

Info

Publication number
US20060079715A1
US20060079715A1 US11/288,549 US28854905A US2006079715A1 US 20060079715 A1 US20060079715 A1 US 20060079715A1 US 28854905 A US28854905 A US 28854905A US 2006079715 A1 US2006079715 A1 US 2006079715A1
Authority
US
United States
Prior art keywords
compound
formula
ethyl
octylphenyl
propane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/288,549
Inventor
Stephan Abel
Tetsuro Fujita
Ryoji Hirose
Guido Jordine
Tadashi Mishina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9824706.7A external-priority patent/GB9824706D0/en
Priority claimed from GBGB9824705.9A external-priority patent/GB9824705D0/en
Application filed by Individual filed Critical Individual
Priority to US11/288,549 priority Critical patent/US20060079715A1/en
Publication of US20060079715A1 publication Critical patent/US20060079715A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/093Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/093Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/20Preparation of halogenated hydrocarbons by replacement by halogens of halogen atoms by other halogen atoms
    • C07C17/202Preparation of halogenated hydrocarbons by replacement by halogens of halogen atoms by other halogen atoms two or more compounds being involved in the reaction
    • C07C17/208Preparation of halogenated hydrocarbons by replacement by halogens of halogen atoms by other halogen atoms two or more compounds being involved in the reaction the other compound being MX
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/35Preparation of halogenated hydrocarbons by reactions not affecting the number of carbon or of halogen atoms in the reaction
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C22/00Cyclic compounds containing halogen atoms bound to an acyclic carbon atom
    • C07C22/02Cyclic compounds containing halogen atoms bound to an acyclic carbon atom having unsaturation in the rings
    • C07C22/04Cyclic compounds containing halogen atoms bound to an acyclic carbon atom having unsaturation in the rings containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms

Definitions

  • the present invention relates to a process for the production of 2-amino-2-[2-(4-C 2-20 -alkyl-phenyl)ethyl]propane-1,3-diols, particularly 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol of formula hereinafter defined as Compound A.
  • EP-A1-627,406 2-Amino-2-[2-(4-C 2-20 -alkyl-phenyl)ethyl]propane-1,3-diols are disclosed in EP-A1-627,406 the relevant disclosure of which is incorporated herein by reference.
  • EP-A1-627,406 they have been found to be useful e.g. as immunosuppressants, e.g. in the prevention or treatment of acute allograft rejection or autoimmune diseases, or e.g. as described in WO 98/22100, in the prevention or treatment of xenograft rejection.
  • Any alkyl group mentioned herein may be a straight or branched chain alkyl group.
  • C 2-20 alkyl is octyl, particularly straight chain.
  • protecting groups as R 3 are e.g. disclosed in “Protective Groups in Organic Synthesis”, T. W. Greene, J. Wiley & Sons New York (1981), 219-287, e.g. acyl such as formyl, acetyl, benzoyl; alkoxycarbonyl e.g. t.-butyloxycarbonyl; allyloxycarbonyl; trityl; etc.
  • the reduction step g) may conveniently be performed using a reducing agent, e.g. NaBH 4 .
  • a reducing agent e.g. NaBH 4 .
  • the following treatment with an anhydride may be effected e.g. with acetic anhydride, preferably in the presence of a neutralizing agent, e.g. an aliphatic or organic amine, e.g. pyridine.
  • Suitable basic compounds for use in step i) include an alkali metal hydroxide, e.g. NaOH, KOH or LiOH.
  • Step i) may preferably be carried out in a polar solvent, e.g. an alcohol such as methanol, at reflux.
  • Step j) may be effected in accordance with known hydrogenation methods, e.g. in the presence of a hydrogenation catalyst, e.g. Pd—C.
  • a 2-amino-2-[2-(4-C 2-20 alkylphenyl)ethyl]propane-1,3-diol in free form or in salt form may be prepared by
  • Steps h) and N) may be effected in accordance with methods known in the art, e.g. as disclosed above for steps j) and i), respectively, or in Examples 4 and 5 hereinafter.
  • the reduction may comprise either a hydrogenation step, e.g. as disclosed above for step (j), followed by a reduction step, e.g. as disclosed above for step (g), or a reduction step as diclosed for step (g) comprising an intermediary hydrogenation step [e.g. as disclosed for step (j)] prior to the anhydride (R 4 CO) 2 O treatment.
  • Step (N) may be carried out as indicated above.
  • the invention provides a process for preparing 2-amino-2-[2-(4-C 2-20 alkylphenyl)ethyl]propane-1,3-diol, in free form or in salt form, which process comprises
  • Process steps (f) and (K) may be performed as disclosed above for (j) and (g), respectively.
  • the reduction step (K) may be carried out in the presence of Ca (BH 4 ) 2 .
  • the latter may be generated by reaction of NaBH 4 with CaCl 2 .
  • Compound of formula (20′) may be prepared as disclosed in PCT/JP98/02998.
  • the invention further provides a process for preparing a 2-amino-2-[2-(4-C 2-20 alkylphenyl)ethyl]propane-1,3-diol, in free form or in salt form, which process comprises
  • Process step (g′) is a reduction carried out in the same manner as in step (g). Suitable reducing agents may be e.g. as disclosed above for step (g). Steps (y) and (z) may be carried out as disclosed above for steps (j) and (N).
  • a compound of formula (21′) as defined above may be reacted with a basic compound, e.g. an alkali metal hydroxide, to obtain a compound of formula (22) as defined above, which compound of formula (22) is then further treated as disclosed above for step (j).
  • a basic compound e.g. an alkali metal hydroxide
  • Suitable alkali metal hydroxide may be e.g. LiOH.
  • Compound of formula (20) used as starting product in the preparation of a 2-amino-2-[2-(4-C 2-20 alkylphenyl)ethyl]propane-1,3-diol, is novel and also forms part of the present invention, as well as its preparation.
  • Compound of formula (20) may be obtained by a process comprising
  • Process step (a) may be performed in accordance with known bromoacetylation methods, e.g. in the presence of AlCl 3 .
  • Process step (d) may conveniently be effected in the presence of sodium ethylate, in an anhydrous solvent such as anhydrous ethanol, and under an inert atmosphere, e.g. nitrogen, e.g. as disclosed in Example 13.
  • Compound of formula (18) used in above step (d) may also be prepared by reacting a compound of formula (16) as defined above, with acetyl chloride to obtain a compound of formula (18′) wherein R is as defined above, which compound of formula (18′) is then brominated.
  • the invention further provides a process for preparing a 2-amino-2-[2-(4-C 2-20 alkylphenyl)ethyl]propane-1,3-diol, in free form or in salt form, which process comprises
  • Process step (H) may preferably be effected in the presence of sodium ethylate, e.g. as disclosed for step (d) above.
  • Process step (c) may conveniently be performed by reaction with an iodinating agent, e.g. an alkali metal iodide such as Nal or Kl.
  • Process step (l) may be carried out under acidic conditions, e.g. trifluoroacetic acid.
  • Suitable reducing agents include e.g. triethylsilane.
  • Process step (C) may be performed as disclosed e.g. for (j).
  • Process step (C′) may be carried out in accordance with methods known in the art, e.g. using a brominating agent, e.g. HBr, in the presence of a phase transfer-catalyst, e.g. an ammonium salt such as tricaprylmethylammonium halogenide, and further purification using e.g. aluminium oxide.
  • a brominating agent e.g. HBr
  • a phase transfer-catalyst e.g. an ammonium salt such as tricaprylmethylammonium halogenide
  • Process step (b) may be carried out as disclosed for step (l) above.
  • a compound of formula (2) as defined above preferably in the presence of a base, e.g. an alkali metal hydride such as NaH, or an alkali metal alkoxide, e.g. C 2 H 5 ONa or t.-C 4 H 9 OK.
  • a base e.g. an alkali metal hydride such as NaH, or an alkali metal alkoxide, e.g. C 2 H 5 ONa or t.-C 4 H 9 OK.
  • Process step e) may be carried out in accordance with known methods or e.g. as disclosed in Example 20.
  • Compound A is preferably prepared
  • the present invention also comprises each of the following steps disclosed above, respectively: step (b), step (c), step (C′), step (e), step (d), step (g′), step (g), step (x), step (f).
  • salts include salts with inorganic acids, such as hydrochloride, hydrobromide, and sulfate, salts with organic acids, such as acetate, lactate, succinate or tartarate, fumarate, maleate, benzoate, citrate, malate, methanesulfonate and benzenesulfonate salts.
  • Preferred salt is the hydrochloride salt.
  • 2-amino-2-[2-(4-C 2-20 alkylphenyl)ethyl]-propane-1,3-diols, preferably Compound A may be converted into the hydrochloride salt form in accordance with known methods, e.g. by addition of HCl to the last reaction step such as in step (j), or prior to recrystallization such as in step (N).
  • 2-Amino-2-[2-(4-C 2-20 alkylphenyl)ethyl]propane-1,3-diols and/or the intermediate compounds may be purified and/or separated by a conventional manner such as recrystallization, column chromatography, distillation, centrifugal separation, washing or drying.
  • diethyl acetamido-2-(4-octylphenyl)-2-oxoethylmalonate (20) (2.00 g) in methanol (8 ml) is added sodium borohydride (858 mg) and the mixture is stood at room temperature for 1.5 hr.
  • the suspension is diluted with ethyl acetate and washed successively with 1 N HCl, saturated aqueous NaHCO 3 solution and saturated brine.
  • the ethyl acetate layer is dried over anhydrous MgSO 4 and concentrated.
  • pyridine (4 ml)-acetic anhydride (8.8 ml) is stood at room temperature overnight.
  • IR KBr 3400 (sh), 3250, 3050 (sh), 2910, 2850, 1580, 1520, 1470, 1060 cm ⁇ 1 .
  • compound (20) may be hydrogenated in ethanol in the presence of 5% Pd/C and then treated with NaBH 4 and then with acetic anhydride-pyridine as disclosed above.
  • diethyl acetamido-2-(4-octylphenyl)ethylmalonate (8) is prepared by hydrogenation of diethyl acetamido-2-(4-octan-1′-oylphenyl)-ethylmalonate in the presence of 5% Pd/carbon as disclosed above.
  • Compound (8) has the same physico-chemical characteristics as indicated above.
  • UV ⁇ max (MeOH) nm ( ⁇ ): 219.1(5017), 259.2(303.5), 264.5(392.4), 272.7(357.7).
  • the reaction mixture is poured into ice water and the precipitated crystals are collected by filtration.
  • the precipitate is recrystallized from hexane/ethyl acetate (2/1) to give the title compound (9) as colorless crystals.
  • the resulting Compound (9) has the same physico-chemical characteristics as indicated in Example 4.
  • the reduction of Compound (8) may be carried out using NaBH 4 and CaCl 2 , e.g. in aqueous ethanol.
  • the resulting Compound (18) has the same physico-chemical characteristics as indicated in Example 11.
  • 2-(4-octylphenyl)ethanol (5) (46.9 g) is added within 10 min to an aqueous solution containing 3.05 g Na 2 SO 3 , 252.9 g 48% HBr and 3.2 g tricaprylmethylammonium chloride.
  • the reaction mixture is heated to 100° C. for 18 to 22 hours with stirring.
  • the resulting 2-phase mixture is cooled to room temperature, diluted with toluene (150 ml) and the aqueous phase is then removed.
  • the organic phase is washed twice with a volume of 100 ml of a 9% NaHCO 3 solution.
  • the organic phase is treated with basic aluminium oxide, then filtered.
  • the filter residue is washed with toluene (50 ml) and evaporated to yield compound (19) as a clear pale yellow oil.
  • the resulting Compound (19) has the same physico-chemical characteristics as indicated in Example 14.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Disclosed is a process for the production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols.

Description

  • The present invention relates to a process for the production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols, particularly 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol of formula
    Figure US20060079715A1-20060413-C00001

    hereinafter defined as Compound A.
  • 2-Amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols are disclosed in EP-A1-627,406 the relevant disclosure of which is incorporated herein by reference. On the basis of observed activity, e.g. as described in EP-A1-627,406, they have been found to be useful e.g. as immunosuppressants, e.g. in the prevention or treatment of acute allograft rejection or autoimmune diseases, or e.g. as described in WO 98/22100, in the prevention or treatment of xenograft rejection.
  • In accordance with the present invention, new processes for an improved production route of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols, particularly Compound A, in free form or in salt form, have now been found. It is to be understood hereinafter that the process steps of the invention may lead to 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols in free form which may be converted into a salt form, or vice versa.
  • Accordingly, there is provided a process for preparing a 2-amino-2-[2-(4-C2-20alkyl phenyl)ethyl]propane-1,3-diol, in free form or in salt form, which process comprises
  • g) reducing a compound of formula (20)
    Figure US20060079715A1-20060413-C00002

    wherein R is C2-20alkyl, each of R1 and R2, independently, is C1-4alkyl and R3 is a protecting group,
    followed by a treatment with (R4—CO)2O wherein R4 is C1-4alkyl, to obtain a compound of formula (21)
    Figure US20060079715A1-20060413-C00003

    wherein R, R3 and R4 are as defined above; and
  • i) treating the resulting compound of formula (21) with a basic compound to obtain a compound of formula (22)
    Figure US20060079715A1-20060413-C00004

    wherein R is as defined above; and
  • j) hydrogenating the resulting compound (22)
  • Any alkyl group mentioned herein may be a straight or branched chain alkyl group. Preferably C2-20alkyl is octyl, particularly straight chain.
  • Examples of protecting groups as R3 are e.g. disclosed in “Protective Groups in Organic Synthesis”, T. W. Greene, J. Wiley & Sons New York (1981), 219-287, e.g. acyl such as formyl, acetyl, benzoyl; alkoxycarbonyl e.g. t.-butyloxycarbonyl; allyloxycarbonyl; trityl; etc.
  • The reduction step g) may conveniently be performed using a reducing agent, e.g. NaBH4. The following treatment with an anhydride may be effected e.g. with acetic anhydride, preferably in the presence of a neutralizing agent, e.g. an aliphatic or organic amine, e.g. pyridine.
  • Suitable basic compounds for use in step i) include an alkali metal hydroxide, e.g. NaOH, KOH or LiOH. Step i) may preferably be carried out in a polar solvent, e.g. an alcohol such as methanol, at reflux. Step j) may be effected in accordance with known hydrogenation methods, e.g. in the presence of a hydrogenation catalyst, e.g. Pd—C.
  • As an alternative to above process, a 2-amino-2-[2-(4-C2-20alkylphenyl)ethyl]propane-1,3-diol in free form or in salt form may be prepared by
  • h) hydrogenating a compound of formula (21) as defined above to obtain a compound of formula (9)
    Figure US20060079715A1-20060413-C00005

    wherein R, R3 and R4 are as defined above; and
  • N) treating the resulting compound of formula (9) with a basic compound.
  • Steps h) and N) may be effected in accordance with methods known in the art, e.g. as disclosed above for steps j) and i), respectively, or in Examples 4 and 5 hereinafter.
  • According to a further embodiment of the invention, there is provided a process for preparing 2-amino-2-[2-(4-C2-20alkylphenyl)ethyl]propane-1,3-diol, in free form or in salt form, which process comprises
  • x) reducing a compound of formula (20) as defined above, followed by a treatment with (R4CO)2O to obtain a compound of formula (9) as defined above; and
  • N) treating the resulting compound of formula (9) with a basic compound.
  • In process step x) the reduction may comprise either a hydrogenation step, e.g. as disclosed above for step (j), followed by a reduction step, e.g. as disclosed above for step (g), or a reduction step as diclosed for step (g) comprising an intermediary hydrogenation step [e.g. as disclosed for step (j)] prior to the anhydride (R4 CO)2O treatment. Step (N) may be carried out as indicated above.
  • In a further or alternative embodiment, the invention provides a process for preparing 2-amino-2-[2-(4-C2-20alkylphenyl)ethyl]propane-1,3-diol, in free form or in salt form, which process comprises
  • f) hydrogenating a compound of formula (20) as defined above or a compound of formula (20′)
    Figure US20060079715A1-20060413-C00006

    wherein R1, R2 and R3 are as defined above, and R′ is C1-19—CO— to obtain a compound of formula (8)
    Figure US20060079715A1-20060413-C00007

    wherein R and R1 to R3 are as defined above; and
  • K) reducing the resulting compound of formula (8) followed by a treatment with (R4CO)2O to obtain a compound of formula (9) as defined above; and
  • N) treating the resulting compound of formula (9) with a basic compound.
  • Process steps (f) and (K) may be performed as disclosed above for (j) and (g), respectively. Alternatively, the reduction step (K) may be carried out in the presence of Ca (BH4)2. The latter may be generated by reaction of NaBH4 with CaCl2.
  • Compound of formula (20′) may be prepared as disclosed in PCT/JP98/02998.
  • In a further or alternative embodiment, the invention further provides a process for preparing a 2-amino-2-[2-(4-C2-20alkylphenyl)ethyl]propane-1,3-diol, in free form or in salt form, which process comprises
  • g′) reducing a compound of formula (20) as defined above under conditions to obtain a compound of formula (21′)
    Figure US20060079715A1-20060413-C00008

    wherein R and R3 are as defined above; and
  • y) hydrogenating the resulting compound of formula (21′) to obtain a compound of formula (21″)
    Figure US20060079715A1-20060413-C00009

    wherein R and R3 are as defined above; and
  • z) treating the resulting compound of formula (21″) with a basic compound.
  • Process step (g′) is a reduction carried out in the same manner as in step (g). Suitable reducing agents may be e.g. as disclosed above for step (g). Steps (y) and (z) may be carried out as disclosed above for steps (j) and (N).
  • As an alternative to above step (y),
  • i′) a compound of formula (21′) as defined above may be reacted with a basic compound, e.g. an alkali metal hydroxide, to obtain a compound of formula (22) as defined above, which compound of formula (22) is then further treated as disclosed above for step (j).
  • Suitable alkali metal hydroxide may be e.g. LiOH.
  • Compound of formula (20), used as starting product in the preparation of a 2-amino-2-[2-(4-C2-20alkylphenyl)ethyl]propane-1,3-diol, is novel and also forms part of the present invention, as well as its preparation. Compound of formula (20) may be obtained by a process comprising
  • a) reacting a compound of formula (16)
    Figure US20060079715A1-20060413-C00010

    wherein R is as defined above, with 2-bromoacetyl chloride to obtain a compound of formula (18)
    Figure US20060079715A1-20060413-C00011

    wherein R is as defined above; and
  • d) reacting the resulting compound of formula (18) with a compound of formula (2)
    Figure US20060079715A1-20060413-C00012

    wherein R1 to R3 are as defined above.
  • Process step (a) may be performed in accordance with known bromoacetylation methods, e.g. in the presence of AlCl3. Process step (d) may conveniently be effected in the presence of sodium ethylate, in an anhydrous solvent such as anhydrous ethanol, and under an inert atmosphere, e.g. nitrogen, e.g. as disclosed in Example 13. Compound of formula (18) used in above step (d) may also be prepared by reacting a compound of formula (16) as defined above, with acetyl chloride to obtain a compound of formula (18′)
    Figure US20060079715A1-20060413-C00013

    wherein R is as defined above, which compound of formula (18′) is then brominated.
  • In a further or alternative embodiment, the invention further provides a process for preparing a 2-amino-2-[2-(4-C2-20alkylphenyl)ethyl]propane-1,3-diol, in free form or in salt form, which process comprises
  • H) reacting a compound of formula (7)
    Figure US20060079715A1-20060413-C00014

    wherein R is as defined above, with a compound of formula (2) as defined above, to obtain a compound of formula (8) as defined above; and further submitting the resulting compound of formula (8) first to step (K) and then to step (N) as disclosed above.
  • Process step (H) may preferably be effected in the presence of sodium ethylate, e.g. as disclosed for step (d) above.
  • Compound of formula (7) used in process step (H) may be prepared by
  • c) iodinating a compound of formula (19)
    Figure US20060079715A1-20060413-C00015

    wherein R is as defined above; or
  • l) reducing a compound of formula (7′)
    Figure US20060079715A1-20060413-C00016

    wherein R′ is as defined above.
  • Process step (c) may conveniently be performed by reaction with an iodinating agent, e.g. an alkali metal iodide such as Nal or Kl. Process step (l) may be carried out under acidic conditions, e.g. trifluoroacetic acid. Suitable reducing agents include e.g. triethylsilane.
  • Compound of formula (19), used as starting product in the preparation of 2-amino-2-[2-(4-C2-20alkylphenyl)ethyl]propane-1,3-diol, is novel and also forms part of the present invention as well as its preparation. Compound of formula (19) may be obtained by
  • C) hydrogenating a compound of formula (10)
    Figure US20060079715A1-20060413-C00017

    wherein R′ is as defined above, to obtain a compound of formula (5)
    Figure US20060079715A1-20060413-C00018

    wherein R is as defined above; and
  • C′) brominating the resulting compound of formula (5).
  • Process step (C) may be performed as disclosed e.g. for (j). Process step (C′) may be carried out in accordance with methods known in the art, e.g. using a brominating agent, e.g. HBr, in the presence of a phase transfer-catalyst, e.g. an ammonium salt such as tricaprylmethylammonium halogenide, and further purification using e.g. aluminium oxide.
  • Compound of formula (19) may also be prepared by
  • b) reducing a compound of formula (18) as defined above.
  • Process step (b) may be carried out as disclosed for step (l) above.
  • Compound of formula (19) is useful to prepare the intermediary compound of formula (8) used in process step (K)
  • e) directly by reaction with a compound of formula (2) as defined above, preferably in the presence of a base, e.g. an alkali metal hydride such as NaH, or an alkali metal alkoxide, e.g. C2H5 ONa or t.-C4H9OK.
  • Process step e) may be carried out in accordance with known methods or e.g. as disclosed in Example 20.
  • According to the invention, Compound A is preferably prepared
  • either starting from a compound of formula (19) and following above disclosed route: step (e)
    Figure US20060079715A1-20060413-P00900
    step (K)
    Figure US20060079715A1-20060413-P00900
    step (N);
  • or starting from a compound of formula (7) and following above disclosed route: step (H)
    Figure US20060079715A1-20060413-P00900
    step (K)
    Figure US20060079715A1-20060413-P00900
    step (N);
  • or starting from a compound of formula (20) or (20′) and following above disclosed route: step (f)
    Figure US20060079715A1-20060413-P00900
    step (K)
    Figure US20060079715A1-20060413-P00900
    step (N).
  • The present invention also comprises each of the following steps disclosed above, respectively: step (b), step (c), step (C′), step (e), step (d), step (g′), step (g), step (x), step (f).
  • Examples of salts include salts with inorganic acids, such as hydrochloride, hydrobromide, and sulfate, salts with organic acids, such as acetate, lactate, succinate or tartarate, fumarate, maleate, benzoate, citrate, malate, methanesulfonate and benzenesulfonate salts. Preferred salt is the hydrochloride salt. 2-amino-2-[2-(4-C2-20alkylphenyl)ethyl]-propane-1,3-diols, preferably Compound A, may be converted into the hydrochloride salt form in accordance with known methods, e.g. by addition of HCl to the last reaction step such as in step (j), or prior to recrystallization such as in step (N).
  • 2-Amino-2-[2-(4-C2-20alkylphenyl)ethyl]propane-1,3-diols and/or the intermediate compounds may be purified and/or separated by a conventional manner such as recrystallization, column chromatography, distillation, centrifugal separation, washing or drying.
  • The present Examples are illustrative of the invention.
  • EXAMPLE 1 Production of 2-acetamido-4-acetoxy-2-acetoxymethyl-4-(4-octylphenyl)butyl acetate (21) [Step (g)]
  • To a solution of diethyl acetamido-2-(4-octylphenyl)-2-oxoethylmalonate (20) (2.00 g) in methanol (8 ml) is added sodium borohydride (858 mg) and the mixture is stood at room temperature for 1.5 hr. The suspension is diluted with ethyl acetate and washed successively with 1 N HCl, saturated aqueous NaHCO3 solution and saturated brine. The ethyl acetate layer is dried over anhydrous MgSO4 and concentrated. To the residue is added pyridine (4 ml)-acetic anhydride (8.8 ml), and the mixture is stood at room temperature overnight. To the reaction mixture is added ice water and the mixture is extracted with ethyl acetate and washed successively with 1 N HCl, saturated aqueous NaHCO3 solution and saturated brine. The ethyl acetate layer is dried over anhydrous MgSO4 and concentrated. The residue is purified by silica gel column chromatography using hexane-ethyl acetate as eluent to give the title compound (21) as a colorless oil.
  • TLC Rf: 0.3 (hexane/ethyl acetate=½, silica gel 60F254 plate)
  • IR (CCl4) 3390, 2930, 2860, 1750, 1690, 1510, 1370, 1230, 1040 cm−1.
  • 1H-NMR (500 MHz, CDCl3) δ: 7.22 (2H, d, J=8.1 Hz, C6H2), 7.14 (2H, d, J=8.1 Hz, C6H2), 5.91 (1H, brs, NH), 5.84 (1H, dd, J=4.2 and 8.5 Hz, CH), 4.37 (1H, d, J=11.2 Hz, OCHa), 4.34 (1H, d, J=11.2 Hz, OCHb), 4.34 (2H, s, OCH2), 2.56 (2H, t, J=7.8 Hz, PhCH2), 2.54 (1H, dd, J=4.2 and 15.1 Hz, CHCHa), 2.36 (1H, dd, J=8.5 and 11.5 Hz, CHCHb), 2.10, 2.07 and 1.99 (each 3H, s, OAc), 1.90 (3H, s, NAc), 1.57 (2H, qui, J=7.8 Hz, CH2), 1.32−1.23 (10H, m, CH2×5), 0.87 (3H, t, J=7. 1 Hz, CH3)
  • FAB-MS m/z: 432 (M−AcOH+H)+
  • EXAMPLE 2 Production of 2-amino-2-(2-hydroxy-2-(4-octylphenyl)ethyl)propane-1,3-diol (22) [Step (i)]
  • 2-Acetamido-4-acetoxy-2-acetoxymethyl-4-(4-octylphenyl)butyl acetate (21) (700 mg) is refluxed under heating for 5 hr in methanol (3.6 ml)/1 N NaOH (7.2 ml). The reaction mixture is diluted with water and subjected to XAD-II column using water and methanol as eluents. The methanol eluate is concentrated to give the title compound (22) as a pale-yellow solid. TLC Rf:0.5 (chloroform/methanol/acetic acid/water=70/20/6/4, silica gel 60F254 plate) IR (KBr) 3340, 2930, 2850, 1470, 1040 cm−1.
  • 1H-NMR (500 MHz, DMSO-d6) δ: 7.20 (2H, d, J=8.1 Hz, C6H2), 7.10 (2H, d, J=8.1 Hz, C6H2), 6.66 (1H, brs, CHOH), 4.83 (1H, dd, J=3.0 and 10.0 Hz, CH), 4.72 and 4.61 (each 1H, brs, OH), 3.42 (2H, s, OCH2), 3.25 (1H, d, J=10.5 Hz, OCHa), 3.21 (1H, d, J=10.3 Hz, OCHb), 2.52 (2H, t, J=7.6 Hz, PhCH2), 1.71 (2H, brs, NH2), 1.55−1.51 (2H, m, CH2), 1.51 (1H, dd, J=3.2 and 14.4 Hz, CHCHa), 1.47 (1H, dd, J=10.1 and 14.4 Hz, CHCHb), 1.27−1.23 (10H, m, CH2×5), 0.85 (3H, t, J=7.1 Hz, CH3)
  • FAB-MS m/z: 324 (M+H)+
  • EXAMPLE 3 Production of 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride (Compound A in hydrochloride Salt Form) [Step (j)]
  • 5% Pd/carbon (13 mg) is suspended in ethanol (0.5 ml) and a solution of 2-amino-2-[2-hydroxy-2-(4-octylphenyl)ethyl]propane-1,3-diol (22) (107 mg) in ethanol (4 ml)-1 N HCl in ethanol (0.55 ml) is added. The mixture is stirred at room temperature for 10 days under 5 kg/cm2 hydrogen pressurization. The reaction mixture is filtered and the filtrate is concentrated to Compound A (hydrochloride) as colorless crystals.
  • Decomposition: 260° C.
  • TLC Rf: 0.55 (chloroform/methanol/acetic acid/water=70/20/6/4, silica gel 60F254 plate) IR (KBr) 3400 (sh), 3250, 3050 (sh), 2910, 2850, 1580, 1520, 1470, 1060 cm−1.
  • UVλmax,(H2O) nm (ε): 210.7(4709), 264(392.4), 272(341.1)
  • 1H-NMR (500 MHz, DMSO-d6) δ: 7.91 (3H, br s, NH3 +), 7.09 (2H, d, J=8.5 Hz, C6-H2), 7.07 (2H, d, J=8.5 Hz, C6-H2), 5.38 (2H, br s, OH×2), 3.51 (4H, s, CH2OH×2), 2.56 (2H, m, Ph—CH2), 2.49 (2H, m, Ph—CH2), 1.77 (2H, m, CH2), 1.51 (2H, m, CH2), 1.25 (10H, m, CH2×5), 0.83 (3H, t, J=7.5 Hz, CH3)
  • EIMS m/z: 276 (M- CH2OH)+, 117, 105
  • EXAMPLE 4 Production of 2-acetamido-2-acetoxymethyl-4-(4-octylphenyl)butyl acetate (9) [Step (h)]
  • 5% Pd/carbon (20 mg) is suspended in ethyl acetate (0.5 ml) and a solution of 2-acetamido-4-acetoxy-2-acetoxymethyl-4-(4-octylphenyl)butyl acetate (21) (200 mg) in ethyl acetate (5 ml) and acetic acid (0.2 ml) are added. The mixture is stirred at room temperature for 6 days under 5 kg/cm2 hydrogen pressurization. The reaction mixture is filtered and the filtrate is washed successively with saturated aqueous NaHCO3 solution and saturated brine. The ethyl acetate layer is dried over anhydrous MgSO4 and concentrated to give the title compound (9) as colorless crystals. m.p. 111.8° C.
  • TLC Rf:0.4 (hexane/ethyl acetate=½, silica gel 60F254 plate)
  • IR (KBr) 3330, 2910, 2850, 1740, 1650, 1550, 1470, 1390, 1260, 1240, 1050 cm−1.
  • UVλmax,(MeOH) nm (ε): 217.6(4772), 259.0(305.7), 264.5(394.6), 272.8(368.6)
  • 1H-NMR (270 MHz, DMSO-d6) δ: 7.63 (1H, br s, NH), 7.07 (4H, s, C6-H4), 4.28 (2H, d, J=10.6 Hz, CHaOAc×2), 4.18 (2H, d, J=10.6 Hz, CHbOAc×2), ca. 2.5 (4H, m, Ph—CH2×2), 2.02 (6H, s, OCOCH3,×2), 1.94 (2H, m, CH2), 1.85 (3H, s, NCOCH3), 1.52 (2H, m, CH2), 1.24 (10H, m, CH2×5), 0.85 (3H, t, J=7.2 Hz, CH3)
  • EIMS m/z: 433 (M)*, 373, 360, 300, 216, 157, 117, 105, 97
  • EXAMPLE 5 Production of 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride (Compound A in hydrochloride salt form) [Step (N)]
  • 2-Acetamido-2-acetoxymethyl-4-(4-octylphenyl)butyl acetate (9) (7.37 kg) is refluxed under heating in methanol (51 L)-2N aqueous NaOH solution (34 L) for 6 hr. After cooling, the resulting precipitate is collected by filtration and washed thoroughly with water. The precipitate is dissolved in conc. HCl/ethanol (1:11) (20 L) and concentrated. The residue is recrystallized from ethyl acetate/ethanol to give Compound A (hydrochloride) as colorless crystals. The resulting Compound A has the same physico-chemical characteristics as indicated in Example 3.
  • EXAMPLE 6 Production of 2-acetamido-2-acetoxymethyl-4-(4-octylphenyl)butyl acetate (9) [Step (x)]
  • To a solution of diethyl acetamido-2-(4-octylphenyl)-2-oxoethylmalonate (20) (200 mg) in methanol (0.8 ml) is added sodium borohydride (85 mg) and the mixture is stood at room temperature for 2.5 hr. The reaction mixture is diluted with ethyl acetate and water, 1N HCl (2.24 ml) and acetic acid (0.26 ml) are added, followed by partitioning. The ethyl acetate layer is washed successively with saturated aqueous NaHCO3 solution and saturated brine. The ethyl acetate layer is dried over anhydrous MgSO4 and concentrated. The residue is stirred in ethanol (2 ml) in the presence of 5% Pd/Carbon (20 mg) and acetic acid (0.2 ml) for 8 days under 5 kg/cm2 hydrogen pressurization. The reaction mixture is filtered through a membrane filter and the filtrate is concentrated.
  • The residue is dissolved in acetic anhydride (2.8 ml)-pyridine (1 ml), and the mixture is stood at room temperature overnight. The reaction mixture is poured into ice water and the precipitate is collected by filtration. The precipitate is recrystallized from hexane-ethyl acetate to give the title compound (9) as colorless crystals. The above-mentioned recrystallization filtrate is concentrated and purified by preparative TLC to give further the title compound (9) as colorless crystals. The resulting Compound (9) has the same physico-chemical characteristics as indicated in Example 4.
  • Alternatively compound (20) may be hydrogenated in ethanol in the presence of 5% Pd/C and then treated with NaBH4 and then with acetic anhydride-pyridine as disclosed above.
  • EXAMPLE 7 Production of diethyl acetamido-2-(4-octylphenyl)ethylmalonate (8) [Step (f)]
  • Diethyl acetamido-2-(4-octylphenyl)-2-oxoethylmalonate (20) (200 mg) is stirred at room temperature for 6 days in ethanol (2 ml) in the presence of 5% Pd/carbon (20 mg) under 5 kg/cm2 hydrogen pressurization. The reaction mixture is filtered and the filtrate is concentrated. The residue is dissolved in ethyl acetate and washed successively with saturated aqueous NaHCO3 solution and saturated brine. The ethyl acetate solution is dried over anhydrous MgSO4 and concentrated to give the title compound (8). m.p. 61° C.
  • Alternatively diethyl acetamido-2-(4-octylphenyl)ethylmalonate (8) is prepared by hydrogenation of diethyl acetamido-2-(4-octan-1′-oylphenyl)-ethylmalonate in the presence of 5% Pd/carbon as disclosed above.
  • Compound (8) has the same physico-chemical characteristics as indicated above. TLC Rf: 0.6 (hexane/ethyl acetate=1/1, silica gel 60F254 plate).
  • IR (KBr) 3300, 2920, 2850, 1750, 1650, 1520, 1220, 1200 cm−1.
  • UVλmax,(MeOH) nm (ε): 219.1(5017), 259.2(303.5), 264.5(392.4), 272.7(357.7).
  • 1H-NMR (270 MHz, DMSO-d6) δ: 8.32 (1H, br s, NH), 7.08 (2H, d, J=7.9 Hz, C6-H2), 7.02 (2H, d, J=7.9 Hz, C6-H2), 4.13 (4H, q, J=7.3 Hz, OCH2CH3×2), 2.52 (4H, m, Ph—CH2×2), 2.37 (2H, m, CH2), 1.94 (3H, s, COCH3), 1.52 (2H, m, CH2), 1.24 (10H, m, CH2×5), 1.15 (6H, t, J=7.3 Hz OCH2CH3×2), 0.85 (3H, t, J=6.6 Hz, CH3)
  • EIMS m/z: 388 (M-OCH2CH3)+, 318, 301, 244, 217, 171, 143.
  • EXAMPLE 8 Production of 2-acetamido-2-acetoxymethyl-4-(4-octylphenyl)butyl acetate (9) [Step (K)]
  • To a solution of diethyl acetamido-2-(4-octylphenyl)ethylmalonate (8) (1.37 kg) in methanol (5.5 L) is added sodium borohydride (720 g), and the mixture is stirred at room temperature for 2 hr. The suspension is diluted with ethyl acetate, and washed successively with 4N HCl, saturated aqueous NaHCO3 solution and saturated brine. The ethyl acetate layer is dried over anhydrous magnesium sulfate and concentrated. To the residue are added pyridine (3 L) and acetic anhydride (12 L), and the mixture is stirred at room temperature overnight. The reaction mixture is poured into ice water and the precipitated crystals are collected by filtration. The precipitate is recrystallized from hexane/ethyl acetate (2/1) to give the title compound (9) as colorless crystals. The resulting Compound (9) has the same physico-chemical characteristics as indicated in Example 4.
  • Alternatively, the reduction of Compound (8) may be carried out using NaBH4 and CaCl2, e.g. in aqueous ethanol.
  • EXAMPLE 9 Production of 2-acetamido-2-[2-hydroxy-2-(4-octylphenyl)ethyl]propane-1,3-diol (21′) [Step (g′)]
  • Diethyl 2-acetamido-2-[2-(4-octylphenyl)-2-oxoethyl]malonate (20) (4 g) is dissolved in methanol (150 ml) and sodium borohydride (tablet, 1.64 g) is added. The mixture is stirred for 1 hr under heating at 50° C. The solvent is evaporated and the residue is extracted with ethyl acetate. The extract is washed with brine and dried over sodium sulfate. The solvent is evaporated to give the title compound (21′) as colorless crystals. m. p.118-119° C.
  • IR (KBr): 3228, 2927, 1640, 1566, 1071 cm−1.
  • 1H-NMR (CDCl3): 0.86 (3H, t, J=6 Hz), 1.18-1.33 (10H, m), 1.48-1.64 (2H, m), 1.57 (2H, bs), 1.80 (1H, dd, J=8 Hz, J=10 Hz), 2.02 (3H, s), 2.34 (1H, d, J=10 Hz), 2.56 (2H, t, J=6 Hz), 3.39−3.47 (1H, m), 3.54-3.62 (1H, m), 3.68-3.80 (2H, m), 4.11 (1H, br. s), 4.85 (1H, d, J=7 Hz), 6.96 (1H, br. s), 7.14 (2H, d, J=8 Hz), 7.23 (2H, J=8 Hz)
  • MS (EI) m/z: 365 (M+)
  • EXAMPLE 10 Production of 2-amino-2-[2-hydroxy-2-(4-octylphenyl)ethyl]propane-1,3-diol (22) [Step (i′)]
  • 2-Acetamido-4-(4-octylphenyl)-2-hydroxymethylbutane-1,4-diol (21′) (0.73 g) is dissolved in methanol (10 ml). Thereto is added a solution of LiOH (0.86 g) in water (10 ml), and the mixture is refluxed under heating for 2 hr. The reaction mixture is cooled and extracted with ethyl acetate. The organic layer is washed with brine and dried over sodium sulfate. The solvent is distilled away and the mixture is purified by silica gel column chromatography to give the title compound (22) as a colorless and amorphous powder. The resulting Compound (22) has the same physico-chemical characteristics as indicated in Example 2.
  • EXAMPLE 11 Production of 2-bromo-4′-octylacetophenone (18) [Step (a)]
  • To a suspension of aluminum chloride (3.88 g) and bromoacetyl chloride (4.56 g) in dichloromethane (5 ml) is added dropwise over 1 hr a solution of octyl-benzene (16) (5.0 g) in dichloromethane (7 ml) under ice-cooling, and the mixture is stirred under ice-cooling for 1 hr. The reaction mixture is poured into ice water and extracted with ethyl acetate. The organic layer is washed successively with HCl, saturated aqueous NaHCO3 solution and saturated brine, dried over anhydrous MgSO4 and concentrated to give the title compound (18) as a colorless oil.
  • TLC Rf: 0.4 (hexane/ethyl acetate=20:1, silica gel 60F254 plate)
  • IR (CCl4) 2930, 2860, 1680, 1610, 1430, 1280, 1180, 1010 cm−1.
  • 1H-HMR (500 MHz, CDCl3) δ: 7.90 (2H, d, J=8.5 Hz, C6H2), 7.29 (2H, d, J=8.5 Hz, C6H2), 4.44 (2H, s, BrCH2), 2.67 (2H, t, J=7.6 Hz, PhCH2), 1.63 (2H, qui, J=7.1 Hz, CH2), 1.32−1.26 (10H, m, CH2×5), 0.88 (3H, t, J=7.1 Hz, CH3)
  • 13C-NMR (500 MHz, CDCl3) δ: 190.93, 149.95, 131.60, 129.05, 128.89, 36.06, 31.82, 31.01, 30.97, 29.38, 29.24, 29.19, 22.63, 14.08
  • EIMS m/z: 312 and 310 (M)+, 217, 91
  • EXAMPLE 12 Production of 2-bromo-4′-octylacetophenone (18)
  • 4′-Octylacetophenone (18′) [Step (a′)]
  • Aluminum chloride (22.6 g) is suspended in dichloroethane (500 ml) and octylbenzene (16) (21.5 g) is added at room temperature. To the mixture is added acetyl chloride (8.87 g) under ice-cooling. The mixture is stirred at room temperature overnight. The reaction mixture is poured into ice water and extracted with ether. The organic layer is washed with brine and dried over sodium sulfate. The solvent is evaporated to give 4′-octylacetophenone (18′) as a colorless oil.
  • 2-Bromo-4′-octylacetophenone (18) [Step (a″)]
  • To a solution of 4′-octylacetophenone (18′) (23.9 g) in acetic acid (100 ml) is added hydrogen bromide-acetic acid solution (25%, 34 ml) under ice-cooling, which is followed by dropwise addition of bromine (5.3 ml). The mixture is heated to 30° C. and stirred for 3 hr. The solvent is distilled away and the mixture is purified by silica gel column chromatography to give 2-bromo-4′-octylacetophenone as colorless crystals.
  • m. p. 33-34° C.
  • The resulting Compound (18) has the same physico-chemical characteristics as indicated in Example 11.
  • EXAMPLE 13 Production of diethyl acetamido-2-(4-octylphenyl)-2-oxoethylmalonate (20) [Step (d)]
  • A solution of 2-bromo-4′-octylacetophenone (18) (5.0 g), diethyl acetamidomalonate (3.85 g) and sodium ethylate (1.20 g) in anhydrous ethanol (50 ml) is refluxed under heating under nitrogen atmosphere for 6 hr. The reaction mixture is diluted with hexane/ethyl acetate, washed with water, dried over anhydrous MgSO4 and concentrated. The residue is purified by silica gel column chromatography using hexane/ethyl acetate as eluent to give the title compound (20) as a pale-yellow oil.
  • TLC Rf: 0.5 (hexane/ethyl acetate=1/1, silica gel 60F264 plate)
  • IR (CCl4): 3420, 2930, 2860, 1750, 1690, 1610, 1490, 1350, 1230, 1200 cm−1.
  • 1H-NMR (500 MHz, CDCl3) δ: 7.87 (2H, d, J=8.3 Hz, C6H2), 7.25 (2H, d, J=8.3 Hz, C6H2), 7.11 (1H, s, NH), 4.26 and 4.40 (each 2H, q, J=7.1 Hz OCH2), 4.23 (2H, s, COCH2), 2.65 (2H, t, J=7.8 Hz, PhCH2), 1.96 (3H, s, Ac), 1.61 (2H, qui, J=7.3 Hz, CH2), 1.30−1.22 (10H, m, CH2×5), 1.23 (6H, t, J=7.1 Hz, CH3×2), 0.87 (3H, t, J=7.1 Hz, CH3)
  • FAB-MS m/z: 448 (M+H)+
  • EXAMPLE 14 Production of 2-(4-octylphenyl)ethyl bromide (19) [Step (b)]
  • To a solution of 2-bromo-4′-octylacetophenone (18) (1.0 g) in trifluoroacetic acid (2.5 ml) is added triethylsilane (1.12 ml) under ice-cooling, and the mixture is stirred at room temperature for 2 hr. The reaction mixture is poured into ice water and hexane and saturated aqueous NaHCO3 solution are added, which is followed by partitioning. The hexane layer is washed with saturated brine, dried over anhydrous MgSO4 and concentrated. The residue is purified by silica gel column chromatography using hexane as eluent to give the title compound (19) as a colorless oil.
  • TLC Rf:0.5 (hexane, silica gel 60F254 plate)
  • IR (CCl4) 2930, 2860, 1510, 1470 cm−1.
  • 1H-NMR (500 MHz, CDCl3) δ: 7.15 (2H, d, J=8.3 Hz, C6H2), 7.12 (2H, d, J=8.3 Hz, C6H2), 3.56 (2H, t, J=7.8 Hz, BrCH2), 3.14 (2H, t, J=7.8 Hz, PhCH2), 2.59 (2H, t, J=7.8 Hz, PhCH2), 1.61 (2H, qui, J=7.6 Hz, CH2), 1.35−1.27 (10H, m, CH2×5), 0.89 (3H, t, J=7.3 Hz, CH3)
  • EIMS m/z: 298 and 296 (M)+, 217, 197 and 199, 117, 105, 91
  • EXAMPLE 15 Production of 2-(4-octylphenyl)ethyl iodide (7) [Step (c)]
  • To a solution of 2-(4-octylphenyl)ethyl bromide (19) (99 mg) in 2-butanone (5 ml) is added Nal (126 mg) and the mixture is refluxed under heating for 3 hr. The reaction mixture is diluted with hexane and washed successively with saturated aqueous sodium sulfite solution and saturated brine. The hexane layer is dried over anhydrous Mg SO4 and concentrated to yield the title compound (7) as a colorless oil.
  • TLC Rf:0.6 (hexane, silica gel 60F254 plate)
  • IR (CCl4) 2930, 2860, 1510, 1470, 1170 cm−1.
  • 1H-NMR (500 MHz, CDCl3) δ: 7.13 (2H, d, J=8.1 Hz, C6H2), 7.10 (2H, d, J=8.1 Hz, C6H2), 3.33 (2H, t, J=7.6 Hz, ICH2) 3.15 (2H, t, J=7.8 Hz, PhCH2), 2.57 (2H, t, J=7.8 Hz, PhCH2), 1.60 (2H, qui, J=7.8 Hz, CH2), 1.34−1.26 (10H, m, CH2×5), 0.88 (3H, t, J=6.6 Hz, CH3)
  • EIMS m/z: 344 (M+), 245, 217, 119, 117, 91, 57, 43
  • EXAMPLE 16 Production of diethyl acetamido-2-(4-octylphenyl)ethylmalonate (8) [Step (H)]
  • To a solution of diethyl acetamidomalonate (277 g) and sodium ethylate (86.6 g) in anhydrous ethanol (850 ml) is added a solution of 2-(4-octylphenyl)ethyl iodide (7) (146 g) in anhydrous tetrahydrofuran (533 ml), and the mixture is refluxed under heating for 6 hr. The reaction mixture is concentrated and partitioned between water and hexane, and the hexane layer is washed three times with water. The obtained hexane layer is dried over anhydrous magnesium sulfate and concentrated. The residue is recrystallized from hexane to give the title compound (8) as colorless crystals. The resulting Compound (8) has the same physico-chemical characteristics as indicated in Example 7.
  • EXAMPLE 17 Production of 2-(4-octylphenyl)ethyl iodide (7) [Step (I)]
  • To a solution of 4′-(2-iodoethyl)octanophenone (200 g) in trifluoroacetic acid (319 ml) is added triethylsilane (195.7 ml) under ice-cooling, and the mixture is stirred at room temperature for 2 hr. The reaction mixture is concentrated, and the residue is distilled away under reduced pressure to give the title compound (7) as a pale-red oil. The resulting Compound (7) has the same physico-chemical characteristics as indicated in Example 15.
  • EXAMPLE 18 Production of 2-(4-octylphenyl)ethanol (5) [Step (C)]
  • 5% Pd/carbon (0.6 g) is added to a solution of 2-(4-octanoylphenyl)ethanol (10) (30 g) in abs. ethanol (150 ml). The mixture is stirred at room temperature for 2.5 hrs under 0.1 bar hydrogen. The reaction mixture is filtered and the filtrate is concentrated to afford compound (5) as a clear pale yellow oil.
  • IR (NaCl): 3300, 2926, 2854, 1513, 1466, 1046 cm−1.
  • 1H-NMR (200 MHz, CDCl3) δ: 7.12 (4H,s,C6H4); 3.87 (2H,t,J=7.7 Hz,CH2O); 2.85 (2H, t, J=7.7 Hz, Ph—CH2); 2.59 (2H, t, J=7.8 Hz, Ph—CH2); 1.61 (2H, q, J=7.8 Hz, CH2); 1.40−1.15 (10H, m, CH2×5); 0.89 (3H, t, 7.3 Hz, CH3)
  • EIMS m/z: 234 (M+), 203, 135, 105
  • EXAMPLE 19 Production of 2-(4-octylphenyl)ethyl bromide (19) [Step (C′)]
  • 2-(4-octylphenyl)ethanol (5) (46.9 g) is added within 10 min to an aqueous solution containing 3.05 g Na2SO3, 252.9 g 48% HBr and 3.2 g tricaprylmethylammonium chloride. The reaction mixture is heated to 100° C. for 18 to 22 hours with stirring. The resulting 2-phase mixture is cooled to room temperature, diluted with toluene (150 ml) and the aqueous phase is then removed. The organic phase is washed twice with a volume of 100 ml of a 9% NaHCO3 solution. The organic phase is treated with basic aluminium oxide, then filtered. The filter residue is washed with toluene (50 ml) and evaporated to yield compound (19) as a clear pale yellow oil. The resulting Compound (19) has the same physico-chemical characteristics as indicated in Example 14.
  • EXAMPLE 20 Production of diethyl acetamido-2-(4-octylphenyl)ethylmalonate (8) [Step (e)]
  • 60% NaH in oil (9.65 g) is added portionwise to a solution of diethyl acetamidomalonate (58.5 g) in dimethylformamide (240 ml) at such a rate to keep the temperature below 10° C. The resulting mixture is stirred for 90 min., the temperature being allowed to increase to room temperature. To this mixture is added dropwise within 15 min. a solution of 2-(4-octylphenyl)ethyl bromide (19) (40 g) in dimethylformamide (40 ml). The reaction mixture is heated to ca. 80° C. within ca. 25 min. and further stirred for ca. 3-5 hrs. After cooling to room temperature, water (280 ml) is added and the resulting mixture is further stirred until a beige precipitate is formed. The mixture is adjusted to pH 7 with 10% H2SO4. After cooling to ca. 2° C., the residue is filtered, washed with 200 ml water and then recrystallized in heptane to yield compound (8) as colorless crystals. The resulting compound (8) exhibits the same physico-chemical characteristics as indicated in Example 7.

Claims (2)

1-32. (canceled)
33. 2-(4-octylphenyl)ethyl bromide.
US11/288,549 1998-11-11 2005-11-29 Production of 2-amino-2-(4-alkylphenyl)ethyl]propane-1,3-diols Abandoned US20060079715A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/288,549 US20060079715A1 (en) 1998-11-11 2005-11-29 Production of 2-amino-2-(4-alkylphenyl)ethyl]propane-1,3-diols

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GBGB9824706.7A GB9824706D0 (en) 1998-11-11 1998-11-11 Organic compounds
GB9824706.7 1998-11-11
GB9824705.9 1998-11-11
GBGB9824705.9A GB9824705D0 (en) 1998-11-11 1998-11-11 Organic compounds
PCT/EP1999/008577 WO2000027798A1 (en) 1998-11-11 1999-11-09 Production of 2-amino-2-[2-(4-c2-20-alkyl-phenyl)ethyl]propane-1,3-diols
US09/850,851 US6605744B2 (en) 1998-11-11 2001-05-08 Production of 2-amin-2-[2-(2-(40-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols
US10/464,294 US7026522B2 (en) 1998-11-11 2003-06-18 Production of 2-amino-2-[2- (4-alkylphenyl) ethyl] propane-1, 3-diols
US11/288,549 US20060079715A1 (en) 1998-11-11 2005-11-29 Production of 2-amino-2-(4-alkylphenyl)ethyl]propane-1,3-diols

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/464,294 Division US7026522B2 (en) 1998-11-11 2003-06-18 Production of 2-amino-2-[2- (4-alkylphenyl) ethyl] propane-1, 3-diols

Publications (1)

Publication Number Publication Date
US20060079715A1 true US20060079715A1 (en) 2006-04-13

Family

ID=26314659

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/850,851 Expired - Lifetime US6605744B2 (en) 1998-11-11 2001-05-08 Production of 2-amin-2-[2-(2-(40-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols
US10/464,294 Expired - Lifetime US7026522B2 (en) 1998-11-11 2003-06-18 Production of 2-amino-2-[2- (4-alkylphenyl) ethyl] propane-1, 3-diols
US11/288,549 Abandoned US20060079715A1 (en) 1998-11-11 2005-11-29 Production of 2-amino-2-(4-alkylphenyl)ethyl]propane-1,3-diols

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09/850,851 Expired - Lifetime US6605744B2 (en) 1998-11-11 2001-05-08 Production of 2-amin-2-[2-(2-(40-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols
US10/464,294 Expired - Lifetime US7026522B2 (en) 1998-11-11 2003-06-18 Production of 2-amino-2-[2- (4-alkylphenyl) ethyl] propane-1, 3-diols

Country Status (10)

Country Link
US (3) US6605744B2 (en)
EP (2) EP1457478B1 (en)
JP (1) JP4503184B2 (en)
AT (1) ATE288414T1 (en)
AU (1) AU1161400A (en)
DE (1) DE69923579T2 (en)
DK (1) DK1129066T3 (en)
ES (2) ES2644413T3 (en)
PT (2) PT1129066E (en)
WO (1) WO2000027798A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001285331B2 (en) 2000-08-31 2006-04-06 Merck & Co., Inc. Phosphate derivatives as immunoregulatory agents
BR0306811A (en) 2002-01-11 2004-10-26 Sankyo Co Compound, pharmacologically acceptable ester thereof, pharmaceutical composition and methods for the prevention or treatment of autoimmune diseases, rheumatoid arthritis and rejection caused by the transplantation of various organs in a mammal
BRPI0507944A (en) 2004-02-24 2007-07-24 Sankyo Co pharmaceutical composition
WO2006010630A1 (en) 2004-07-30 2006-02-02 Novartis Ag Compound formulations of 2-amino-1, 3-propanediol compounds
WO2007022718A1 (en) * 2005-08-25 2007-03-01 Chunde Liu Alkyl aryl alkyl alcohols, their derivations and preparation process thereof
US20090176744A1 (en) * 2007-11-02 2009-07-09 Concert Pharmaceuticals, Inc. Deuterated fingolimod
CN101959845A (en) * 2008-03-19 2011-01-26 诺瓦提斯公司 Process for preparing 2-amino-2-[2-(4-C3-C21-alkyl-phenyl) ethyl] propane-1, 3-diol compound
CN105198760A (en) * 2008-11-11 2015-12-30 诺华股份有限公司 Salts of fingolimod
ES2643161T3 (en) * 2008-11-11 2017-11-21 Novartis Ag Hing crystalline forms of fingolimod
JP5593164B2 (en) * 2010-06-29 2014-09-17 株式会社クラレ Method for producing primary alkyl halide
EP2621889B1 (en) 2010-10-01 2019-07-17 Synthon BV Process for making fingolimod hydrochloride crystals
AU2011322115A1 (en) 2010-10-28 2013-05-30 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of Fingolimod
WO2012071524A1 (en) 2010-11-24 2012-05-31 Ratiopharm Gmbh Arylsulfonate salts of fingolimod and processes for preparation thereof
EP2658840B1 (en) 2010-12-28 2019-07-03 Synthon BV Process for making fingolimod hydrochloride crystals
US9216943B2 (en) 2011-04-29 2015-12-22 Dr. Reddy's Laboratories Ltd. Preparation of fingolimod and its salts
CN103539683A (en) * 2012-07-17 2014-01-29 广东东阳光药业有限公司 New crystal form of drug for treating sclerosis and preparation method thereof
CN102796022B (en) * 2012-08-27 2015-03-25 南京华威医药科技开发有限公司 Method for preparing 2-amino-2-[2-(4-alkyl phenyl) ethyl]-1,3-propanediol hydrochloride
AU2014206588A1 (en) 2013-01-17 2015-07-23 Shilpa Medicare Limited Process for preparation of Fingolimod and its salts
WO2014136047A2 (en) * 2013-03-05 2014-09-12 Biocon Limited A process for the preparation of 2-amino-1,3-propane diol compounds and salts thereof
ES2729404T3 (en) 2013-11-25 2019-11-04 Emcure Pharmaceuticals Ltd Fingolimod hydrochloride process
EP4173623A4 (en) 2020-06-26 2024-07-24 Osaka University THERAPEUTIC AGENT FOR DRUG-INDUCED BRADYCARDIA AND BRADYARRHYTHMIA

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604229A (en) * 1992-10-21 1997-02-18 Yoshitomi Pharmaceutical Industries, Ltd. 2-amino-1,3-propanediol compound and immunosuppressant

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE269856C (en)
JPS5912643B2 (en) 1975-04-03 1984-03-24 和光純薬工業 (株) Production method of phenethyl bromides
JPS52108943A (en) 1976-03-10 1977-09-12 Teikoku Hormone Mfg Co Ltd Alkyl phenyl ketone derivative
JPS5951932B2 (en) 1980-04-14 1984-12-17 東ソー株式会社 Method for producing addition compounds of halobenzenes and olefins
DD269856A1 (en) * 1988-03-03 1989-07-12 Univ Halle Wittenberg LIQUID CRYSTALLINE AMPHIPHILE
US5508272A (en) 1993-06-15 1996-04-16 Bristol-Myers Squibb Company Compounds containing a fused bicycle ring and processes therefor
IT1265101B1 (en) * 1993-07-23 1996-10-30 Erba Carlo Spa DERIVATIVES OF 2-AMINO-4-PHENYL-4-BUTYRIC BONE ACID
DE69524962D1 (en) 1994-08-22 2002-02-14 Welfide Corp BENZENE DERIVATIVES AND THEIR MEDICAL USE
GB9624038D0 (en) 1996-11-19 1997-01-08 Sandoz Ltd Organic compounds
WO1999001420A1 (en) 1997-07-03 1999-01-14 Taito Co., Ltd. Process for the preparation of 2-aminomalonic acid derivatives and intermediates used in the process
JP4079505B2 (en) 1998-04-28 2008-04-23 田辺三菱製薬株式会社 Novel process for the preparation of 2-amino-2- [2- (4-octylphenyl) ethyl] propane-1,3-diol

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604229A (en) * 1992-10-21 1997-02-18 Yoshitomi Pharmaceutical Industries, Ltd. 2-amino-1,3-propanediol compound and immunosuppressant

Also Published As

Publication number Publication date
US20020072635A1 (en) 2002-06-13
EP1457478A3 (en) 2004-12-22
PT1457478T (en) 2017-10-26
EP1129066A1 (en) 2001-09-05
DK1129066T3 (en) 2005-03-29
ATE288414T1 (en) 2005-02-15
US20030229251A1 (en) 2003-12-11
JP4503184B2 (en) 2010-07-14
AU1161400A (en) 2000-05-29
US7026522B2 (en) 2006-04-11
JP2002529441A (en) 2002-09-10
EP1129066B1 (en) 2005-02-02
WO2000027798A1 (en) 2000-05-18
PT1129066E (en) 2005-05-31
DE69923579T2 (en) 2006-01-12
EP1457478B1 (en) 2017-07-19
ES2237970T3 (en) 2005-08-01
DE69923579D1 (en) 2005-03-10
ES2644413T3 (en) 2017-11-28
US6605744B2 (en) 2003-08-12
EP1457478A2 (en) 2004-09-15

Similar Documents

Publication Publication Date Title
US7026522B2 (en) Production of 2-amino-2-[2- (4-alkylphenyl) ethyl] propane-1, 3-diols
JP7398436B2 (en) Methyl 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7 ] Annelene-2-carboxylate salt and method for producing the same
EP2817289B1 (en) Asymmetric synthetic processes for the preparation of aminosulfone compounds
US5225585A (en) Production of fluoxetine and new intermediates
US20140228575A1 (en) Process for the Preparation of Solifenacin and Salts Thereof
PT2029567E (en) Process for the production of benzopyran-2-ol derivatives
JP3173602B2 (en) Novel intermediate for the production of enyne derivatives and its production method
JP2580736B2 (en) Optically active hydroxybenzylamine derivative, intermediate thereof and method for producing the same
JP2007332129A (en) Process for producing optically active 4-amino-3-substituted phenylbutanoic acid
JP3816968B2 (en) Process for the preparation of N-alkyl-N-pyridinyl-1H-indole-1-amine
ES2236067T3 (en) METHOD FOR THE PRODUCTION OF JASMONATE DERIVATIVES AND INTERMEDIATE PRODUCTS OF THE SAME.
JP4874122B2 (en) How to get tolterodine
US11518733B2 (en) Process for preparation of highly pure Fingolimod hydrochloride
TWI500596B (en) Process for the synthesis of 3,4-dimethoxybicyclo(4.2.0)octa-1,3,5-triene-7-carbonitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
KR20080046176A (en) How to Obtain Phenyl Carbamate
US4231962A (en) 3-Phenoxybenzylideneamines and 3-benzylbenzylideneamines
JP3795970B2 (en) Method for producing α, β-unsaturated aldehyde
JP3046401B2 (en) 6- [1- (N-Alkoxyimino) ethyl] salicylic acid derivative and method for producing the same
CA1285571C (en) Anisole derivatives
JP3805392B2 (en) Process for producing 1,1-cyclopropanedimethanol
US20190315669A1 (en) Process for the preparation of hu-910 and crystalline structure thereof
JP4831897B2 (en) Method for producing (2,6-dichloropyridin-4-yl) methanol
JP3632979B2 (en) Method for producing 2-aminomalonic acid derivative and 2-amino-1,3-propanediol derivative
JP3144921B2 (en) Benzyl ester derivative and method for producing the same
JP4058960B2 (en) Indazole derivatives and process for producing the same

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载